|
⚲
|
| Christopher Meldrum | |
|---|---|
| Firm | |
| Address | c/o Avicenna Biosciences, Inc 101 W Chapel Hill Street, Suite 210 Durham, NC 27701 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Avicenna Biosciences Inc | 021-518896 | Executive Officer | 6.0 M of 6.0 M |
||
| Avicenna Biosciences Inc | 021-505963 | Executive Officer | 6.0 M of 10.0 M |
||
| Avicenna Biosciences Inc | 021-469305 | Executive Officer | 3.0 M of 6.0 M |
||
| Avicenna Biosciences Inc | 021-463082 | Executive Officer | 0.1 M of 0.1 M |
||
| Avicenna Biosciences Inc | 021-375400 | Executive Officer | 2.5 M of 2.5 M |
||
| Pique Therapeutics Inc | 021-328478 | Executive Officer | 0.9 M of 1.0 M |
||
| Kylin Therapeutics Inc | 021-111031 | Executive Officer | 0.1 M of 2.0 M |
||
| Pique Therapeutics Inc | 021-131694 | Executive Officer | 0.5 M of 0.6 M |
||